№ lp_1_12022
File format: docx
Character count: 7605
File size: 318 KB
The document outlines the protocol for managing lentiviral vector exposure in research settings at Wayne State University, including treatment options, risk evaluation, and guidelines for reporting incidents.
Year:
2024
Region / City:
Detroit, MI
Topic:
Occupational Health, Post-Exposure Management
Document Type:
Safety Protocol
Organization / Institution:
Wayne State University
Author:
Henry Ford’s Occupational Health Program, OEHS
Target Audience:
WSU researchers, medical professionals
Period of Validity:
Ongoing
Approval Date:
2024
Modification Date:
Not specified
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2021
Region / city:
Towers Lab, International
Topic:
HIV Research, DNA-Sensing Pathways, Viral Proteins
Document Type:
Scientific Research Paper
Organization / Institution:
Towers Lab
Author:
James Cai
Target Audience:
Researchers, Scientists, Molecular Biologists
Period of Action:
Not specified
Date of Approval:
Not specified
Date of Modifications:
Not specified
Year:
N/A
Region / city:
N/A
Topic:
Lentiviral vector production
Document type:
Protocol
Organization / institution:
N/A
Author:
N/A
Target audience:
Researchers in molecular biology
Validity period:
N/A
Approval date:
N/A
Date of changes:
N/A
Context description:
Protocol for the production and purification of lentiviral vectors, including detailed steps for DNA transfection, virus collection, and purification using Optiprep.
Year:
2008
Region / city:
N/A
Topic:
Molecular Biology, Genetic Engineering
Document Type:
Scientific Article
Institution / Organization:
N/A
Author:
Weber K, Bartsch U, Stocking C, et al.
Target Audience:
Researchers, Molecular Biologists
Validity Period:
N/A
Approval Date:
2008/03/26
Modification Date:
N/A
Keywords:
Lentiviral vector, Gene cloning, AXL overexpression, Co-immunoprecipitation, Western blot, MPN
Context:
Scientific article detailing the methods of cloning LeGO vectors and producing lentiviral particles for genetic research and analysis.
Year:
2024
Region / City:
Africa
Topic:
Vector Control, Malaria, Genetically Modified Organisms
Document Type:
Consultancy Announcement
Organization:
African Union Development Agency-NEPAD (AUDA-NEPAD)
Author:
Not specified
Target Audience:
Individual Consultants
Period of Validity:
Not specified
Approval Date:
Not specified
Modification Date:
Not specified
Year:
2023
Region / City:
San Francisco
Topic:
Physics, Vector Addition
Document Type:
Educational Activity
Institution:
Northern State University
Author:
Unknown
Target Audience:
Physics Students, Teachers
Effective Period:
N/A
Approval Date:
N/A
Date of Changes:
N/A
Contextual Description:
Educational activity designed for physics students to explore vector addition and resultant displacement through real-world examples of travel directions.
Year:
Not specified
Region / City:
Not specified
Theme:
Viral vectors for Parkinson’s disease research
Document Type:
Request Form
Organization / Institution:
University of Iowa, Viral Vector Core Facility
Author:
Not specified
Target Audience:
Researchers from non-profit and for-profit entities
Period of Validity:
Not specified
Approval Date:
Not specified
Modification Date:
Not specified
Note:
Year
Subject:
Gene Transfer, Targeting, and Therapeutics
Document Type:
Request Form
Organization / Institution:
Salk Institute
Target Audience:
Researchers and Lab personnel
Context:
A form for requesting viral vectors from the Gene Transfer, Targeting, and Therapeutics Facility at the Salk Institute for scientific research purposes.
Note:
Year
Author:
Sheng Fan, John Wheeler, David J. Prior, Marianne Negrini, Andrew J. Cross, Travis F. Hager, David L. Goldsby, David Wallis
Year:
2026
Region / City:
La Jolla, CA
Topic:
Gene Transfer, Viral Vectors
Document Type:
Request Form
Organization / Institution:
Salk Institute for Biological Studies
Author:
GT3 Core Facility
Target Audience:
Researchers, Investigators
Validity Period:
N/A
Approval Date:
N/A
Modification Date:
N/A
Facility:
Gene Transfer, Targeting and Therapeutics Facility
Institution:
Salk Institute for Biological Studies
Document Type:
Viral Vector Request Form
Subject:
Stock Reporter Viral Vectors
Submission Method:
Email to [email protected]
Required Information:
Principal Investigator, Lab Contact, Order Date, Fund Number or PO Number, Billing and Shipping Address
Aliquot Size AAV:
25 µl
Aliquot Size Lentiviral, Retroviral, Rabies:
5 µl
Vector Categories:
rAAV, Cre, DIO, FLEX, DO, Lentivirus, AAV Serotype Kits
Source References:
Addgene; Deisseroth Lab (Stanford University)
Material Transfer Requirement:
MTA required for Deisseroth Lab vectors
Titer Information:
Representative lot titers provided; actual titers may vary
Year:
Not specified
Region / City:
Not specified
Subject:
Physics, Mathematics
Document Type:
Educational Worksheet
Organization / Institution:
Not specified
Author:
Not specified
Target Audience:
Students, Physics and Mathematics learners
Period of Validity:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Contextual description:
Educational worksheet on vector addition methods in algebraic, trigonometric, and component form.
Year:
2023
Region / City:
Not specified
Theme:
Image formats, graphics types
Document Type:
Educational
Organization:
Not specified
Author:
Not specified
Target Audience:
Individuals interested in digital imaging and graphics
Validity Period:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Gene:
Gene
Year:
Not specified
Region / City:
Not specified
Topic:
Primer sequences for vector construction and qRT-PCR
Document Type:
Scientific supplementary data
Institution:
Not specified
Author:
Not specified
Target Audience:
Researchers in molecular biology
Period of Effect:
Not specified
Approval Date:
Not specified
Amendment Date:
Not specified
Context:
Document provides detailed sequences for vector construction primers and qRT-PCR primers used in gene expression studies.
Year:
2017
Award Date:
09-28-2017
Country:
United States
City:
Frederick, MD
Agency:
Department of Veterans Affairs
Contracting Office:
Strategic Acquisition Center – Frederick
Solicitation Number:
VA119A-16-R-0349
Award Number:
VA119A-17-D-0081 and related contract numbers
Program Name:
Veteran Enterprise Contracting for Transformation and Operational Readiness (VECTOR)
Contract Type:
IDIQ
Minimum Contract Amount:
$2,500.00
Number of Awardees:
68
Primary Awardee:
Academy Solutions Group, LLC
NAICS Code:
541611
Point of Contact:
Joshua Dean
Contact Email:
[email protected]
Revision Date:
March 2010
Source System:
FedBizOpps
Year:
2026
Region / city:
Global
Topic:
Gene therapy, AAV vectors
Document type:
Research paper
Author:
Multiple authors
Target audience:
Researchers, medical professionals, biotechnology specialists
Period of action:
Ongoing
Date of approval:
Not specified
Date of modifications:
Not specified
Note:
Year
Context:
A comprehensive set of calculus problems, theorems, and application scenarios, covering limits, derivatives, integrals, and related concepts in mathematics.
Year:
2014–2017
Region / Exam Board:
M1
Subject:
Mechanics
Topic:
Vectors in mechanics
Document Type:
Marking scheme / answer key
Questions Covered:
1–6
Marks Allocation:
Detailed per sub-question
Calculation Methods:
Vector addition, kinematics equations, Pythagoras theorem
Units Used:
m, s, m·s⁻²
Target Audience:
Examiners and students preparing for assessment
Assessment Objectives:
1.1b, 2.1, 2.2a, 3.1a, 3.1b
Year:
2024
Region / City:
Kirkland, Quebec, Canada
Topic:
Artificial Intelligence in Healthcare
Document Type:
News Release
Organization:
Merck Canada
Partner Organization:
Vector Institute
Author:
Marwan Akar, Abhishek Narayan Singh, Tony Gaffney
Target Audience:
General public, healthcare industry, AI research community
Effective Period:
Multi-year agreement starting February 8, 2024
Date of Release:
February 8, 2024
Scope:
Canada and international AI research collaborations
Funding:
Merck Canada investments; Vector Institute funding from Ontario, Government of Canada, industry sponsors
Description:
Press release reporting a partnership between a pharmaceutical company and an AI research institute to collaborate on healthcare innovations and AI research initiatives.
Year:
2019
Region / State:
Washington State
Document type:
Exposure control plan
Subject:
Occupational exposure to bloodborne pathogens
Regulatory basis:
Washington Industrial Safety and Health Act (WISHA); WAC 296-823; WAC 110-300-0106
Responsible authority:
Washington State Department of Labor and Industries (L&I)
Developing organizations:
Snohomish Health District Child Care Health Outreach Program; Public Health – Seattle & King County Child Care Health Program
Target audience:
Early learning providers and child care employees
Sector:
Child care and early learning
Approval date:
September 2019
Review cycle:
Annual review required
Training requirement:
Bloodborne pathogen exposure prevention training
Geographic applicability:
Washington State
Year:
2020
Region / City:
Pittsburgh, PA
Topic:
Occupational Health and Safety, Anesthetic Gases
Document Type:
Policy
Organization:
VA Pittsburgh Healthcare System
Author:
Dr. Steven Graham
Target Audience:
VAPHS and Veterans Research Foundation of Pittsburgh employees working with animals in the VAPHS Animal Research Facility
Period of Action:
Ongoing
Approval Date:
September 15, 2020
Recertification Date:
December 2021
Purpose:
To outline procedures to control and monitor exposure to waste anesthetic gases in the VAPHS Animal Research Program
Date of Last Revision:
N/A